Pulmonary manifestations of systemic lupus erythematosus

Seminars in Respiratory and Critical Care Medicine

Volumn 28, Issue 4, 2007, Pages 441-450

  Memet, Beatrice ^a   Ginzler, Ellen M ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Pleuropulmonary disease; Prognosis; Systemic lupus erythematosus; Treatment

Indexed keywords

ACUTE LUPUS PNEUMONITIS; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; HYPOXEMIA; IMAGING; INFECTION; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG DISEASE; LUNG FUNCTION TEST; LUNG HEMORRHAGE; MIXED CONNECTIVE TISSUE DISEASE; MORBIDITY; MORTALITY; PATHOGENESIS; PLEURA DISEASE; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; REVIEW; SHRINKING LUNG SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY;

HUMANS; LUNG DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIXED CONNECTIVE TISSUE DISEASE; PLEURAL DISEASES; PROGNOSIS; RESPIRATORY TRACT DISEASES;

EID: 35848959260     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985665     Document Type: Review

References (76)

1. Osler W. On the visceral manifestations of the erythema group of skin diseases. Am J Med Sci 1904;127:1-3
2. D'Cruz D, Khamashta M, Hughes G. Pulmonary manifestations of systemic lupus erythematosus. In: Wallace DJ, Hahn BHH, eds. Dubois' Lupus Erythematosus. Philadelphia: Lippincott, Williams and Wilkins; 2002:663-683
3. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971;50:85-94
4. Huang C-T, Hennigar GR, Lyons HA. Pulmonary dysfunction in with systemic lupus erythematosus. N Engl J Med 1965;272:288-293
5. Andonopoulos AP, Constantopoulos SH, Galanopoulou V, Drosos AA, Acritidis NC, Moutsopoulos HM. Pulmonary function of nonsmoking patients with systemic lupus erythematosus. Chest 1988;94:312-315
6. Groen H, ter Borg EJ, Postma DS, Wouda AA, van der Mark TW, Kallenberg CG. Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns. Am J Med 1992;93:619-627
7. Jonsson H, Nived O, Sturfelt G, Valind S, Jonson B. Lung function in patients with systemic lupus erythematosus and persistent chest symptoms. Br J Rheumatol 1989;28:492-499
8. Rolla G, Brussino L, Bertero MT, Bucca C, Converso M, Caligaris-Capio F. Respiratory function in systemic lupus erythematosus: relation with activity and severity. Lupus 1996;5:38-43
9. Scano G, Goti P, Duranti R, Misuri G, Emmi L, Rosi E. Control of breathing in a subset of patients with systemic lupus erythematosus. Chest 1995;108:759-766
10. Gibson CJ, Edmonds JP, Hughes GRV. Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med 1977;63:926-932
11. Hardy K, Herry I, Attali V, Cadranel J, Similowsky T. Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 2001;119:1274-1277
12. Al-Raqum HA, Uppal SS, Al-Mutairy M, Kumari R. Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti. Clin Rheumatol 2006;25:412-414
13. Keane MP, Lynch JP III. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000;55:159-166
14. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 1993;72:113-124
15. Sahn SA. The pathophysiology of pleural effusions. Annu Rev Med 1990;41:7-13
16. Turner-Stokes L, Haslam P, Jones M, et al. Autoantibody and idiotype profile of lung involvement in autoimmune rheumatic disease. Ann Rheum Dis 1990;49:160-162
17. Wiedemann HP, Matthay RA. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989;10:677-722
18. Crestani B. The respiratory system in connective tissue disorders. Allergy 2005;60:715-735
19. Fenlon HM, Doran M, Sant SM, Breatnach E. High resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol 1996;166:301-307
20. Susanto I, Peters JI. Acute lupus pneumonitis with normal chest radiograph. Chest 1997;111:1781-1783
21. Inoue T, Kanayama Y, Ohe A, et al. Immunopathologic studies of pneumonitis in systemic lupus erythematosus. Ann Intern Med 1979;91:30-34
22. Boulware DW, Hedgpeth MT. Lupus pneumonitis and anti-SSA(Ro) antibodies. J Rheumatol 1989;16:479-481
23. Mochizuki T, Aotsuka S, Satoh T. Clinical and laboratory features of lupus patients with complicating pulmonary disease. Respir Med 1999;93:95-101
24. Raj R, Murin S, Matthay RA, Widemann HP. Systemic lupus erythematosus in the intensive care unit. Crit Care Clin 2002;18:781-803
25. Isbister JP, Ralston M, Hayes JM, Wright R. Fulminant lupus pneumonitis with acute renal failure and RBC aplasia: successful management with plasmapheresis and immunosuppression. Arch Intern Med 1981;141:1081-1083
26. Winder A, Molad Y, Osfeld I, et al. Treatment of systemic lupus erythematosus by prolonged administration of high dose of intravenous immunoglobulin: report of 2 cases. J Rheumatol 1993;20:495-498
27. Eiser AR, Shanies HM. Treatment of lupus interstitial lung disease with intravenous cyclophosphamide. Arthritis Rheum 1994;37:428-431
28. Santos-Ocampo AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in systemic lupus erythematosus. Chest 2000;118:1083-1090
29. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus. Am J Med 1981;71:791-798
30. Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome. Medicine 1997;76:192-202
31. Myers JL, Katsenstein AL. Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986;85:552-556
32. Onomura K, Nakata H, Tanakaya Y, Tsuda T. Pulmonary hemorrhage in patients with systemic lupus erythematosus. J Thorac Imaging 1991;6:57-61
33. Orens JB, Martinez FJ, Lynch JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994;20:159-192
34. Dweik RA, Arroliga AC, Cash GM. Alveolar hemorrhage in patients with rheumatic disease. Rheum Dis Clin North Am 1997;23:395-410
35. Erickson RW, Franklin WA, Emlen W. Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum 1994;24:114-123
36. Sant SM, Doran M, Fenelon HM, Breatnach ES. Pleuro-pulmonary abnormalities in patients with systemic lupus erythematous: assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol 1997;15:507-513
37. Bankier AA, Kiener HP, Wiesmayr MN, et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology 1995;196:835-840
38. Ooi GC, Ngan H, Peh WCG, et al. Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. Clin Radiol 1997;52:775-781
39. Jacobsen S, Petersen J, Ullman S, et al. A multicenter study of 513 Danish patients with systemic lupus erythematosus, I: Disease manifestations and analysis of clinical subsets. Clin Rheumatol 1998;17:468-477
40. Weinrib L, Sharma OP, Quismorio FP Jr. A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990;20:48-56
41. Colby TV. Pulmonary pathology in patients with systemic autoimmune diseases. Clin Chest Med 1998;19:587-612
42. Swigris JJ, Olson AL, Fischer A, et al. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue-related interstitial lung disease. Chest 2006;130:30-36
43. Langford CA, Waes C. Upper airway obstruction in the rheumatic diseases: life-threatening complications of autoimmune disease. Rheum Dis Clin North Am 1997;23:345-363
44. Smith GA, Ward PH, Berci G. Laryngeal lupus erythematosus. J Laryngol Otol 1978;92:67-73
45. Teitel AD, MacKenzie CR, Stern R, et al. laryngeal involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1992;22:203-214
46. Curley JW, Byron MA, Bates GJ. Cryco-arytenoid joint involvement in acute systemic lupus erythematosus. J Otol 1986;100:727-732
47. Nossent J, Berend K. Cricoarytenoiditis in systemic lupus erythematosus. Scand J Rheumatol 1998;27:237-238
48. Karim A, Shahid A, Siddiqui R, et al. Severe upper airway obstruction from crycoarytenoiditis as the sole presenting manifestation of a systemic lupus erythematosus flare. Chest 2002;121:990-993
49. Godeau B, Cormier C, Menkes CJ. Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide. Ann Rheum Dis 1991;50:956-958
50. Hinderliter AL, Willis PW, Barst RJ, et al. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension: Primary Pulmonary Hypertension Study Group. Circulation 1997;95:1479-1486
51. Winslow TM, Ossipov MA, Fazio GP, et al. The left ventricle in systemic lupus erythematosus: initial observations and a five-year follow-up in a university medical center population. Am Heart J 1993;125:1117-1122
52. Hosoda Y, Suzuki Y, Takano M, et al. Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study. J Rheumatol 1987;14:826-830
53. Sullivan WD, Hurst DJ, Harmon CE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine 1984;63:92-107
54. Chung SM, Lee CK, Lee EY, Yoo B, Lee SD, Moon HB. Clinical aspects of pulmonary hypertension in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 2006;25:866-872
55. Burdt MA, Hoffman RW, Deutscher SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999;42:899-909
56. Quismorio FP Jr, Shjarma O, Koss M, et al. Immunopathologic and clinical studies in clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984;13:349-359
57. Grunig E, Janssen B, Mereles D, et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 2000;102:1145-1150
58. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary artery hypertension. Chest 2004;126:14S-34S
59. Miyamoto S, Nagaya N, Satoh T, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000;161:487-492
60. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary artery hypertension. N Engl J Med 2004;351:1425-1436
61. Simonson JS, Schiller NB, Petri M, et al. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989;16:918-925
62. Asherson RA, Higenbottom TW, Dihn Xuan AT, et al. Pulmonary hypertension in a lupus clinic: experience with twenty four patients. J Rheumatol 1990;17:1292-1298
63. Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. 1992;327:70-75
64. Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. 1993;328:1732-1739
65. Cella G, Belloto F, Tona F, et al. Plasma markers of endothelial dysfunction in pulmonary hypertension. Chest 2001;120:1226-1230
66. McLaughlin W, Presberg KW, Doyle RL, et al. Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:78S-92S
67. Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-2157
68. Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 1984;70:580-587
69. Abu-Shakra M, Gladman DD, Urowits MB, et al. Anti-cardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations. Am J Med 1995;99:624-628
70. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine 1998;77:195-207
71. Hoffbrand BI, Beck ER. Unexplained dyspnea and shrinking lungs in systemic lupus erythematosus. BMJ 1965;1:1273-1277
72. Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE: a clinical pathologic study. J Rheumatol 1983;10:973-976
73. Laroche CM, Mulvey DA, Hawkins PN, et al. Diaphragm strength in the shrinking lung syndrome of with systemic lupus erythematosus. Q J Med 1989;71:429-439
74. Warrington KJ, Moder KG, Brutinel WM. The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin Proc 2000;75:467-472
75. Abramson SB, Dobro J, Eberle MA, et al. Acute reversible hypoxemia in systemic lupus erythematosus. Ann Intern Med 1991;114:941-947
76. Kim WU, Kim SI, Yoo WH, et al. Adult respiratory distress syndrome in systemic lupus erythematosus: causes and prognostic factors: a single center, retrospective study. Lupus 1999;8:552-557